ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 23 filers reported holding ANI PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $71,000 | +9.2% | 59,000 | 0.0% | 0.00% | – |
| Q1 2019 | $65,000 | +10.2% | 59,000 | 0.0% | 0.00% | – |
| Q4 2018 | $59,000 | -95.6% | 59,000 | -95.1% | 0.00% | -100.0% |
| Q2 2018 | $1,348,000 | +1606.3% | 1,195,000 | +1559.7% | 0.00% | – |
| Q1 2018 | $79,000 | +139.4% | 72,000 | +132.3% | 0.00% | – |
| Q2 2017 | $33,000 | -92.1% | 31,000 | -91.5% | 0.00% | – |
| Q4 2016 | $417,000 | – | 363,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 37,284 | $42,692,000 | 2.46% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,120,000 | 0.79% |
| LINDEN ADVISORS LP | 4,500,000 | $5,156,000 | 0.61% |
| Perceptive Advisors | 7,500,000 | $8,488,000 | 0.51% |
| DINSMORE CAPITAL MANAGEMENT CO/NJ | 1,000,000 | $1,144,000 | 0.45% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $17,425,000 | 0.40% |
| Hudson Bay Capital Management LP | 10,500,000 | $12,052,000 | 0.36% |
| Penn Capital Management Company, LLC | 4,977,000 | $5,674,000 | 0.23% |
| Visium Asset Management, LP | 6,500,000 | $7,471,000 | 0.11% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,000,000 | $6,840,000 | 0.09% |